Top analysts on stock perps · Analyst
Akash Tewari (Jefferies): analyst track record on stock perps
Akash Tewari of Jefferies on companies with stock perpetual futures: star rating, success rate, price-target accuracy, current calls and the measured perp reaction after each rating.
Stars4.8★
Success57%
Excess return+12.3%
rank#601
Ratings391
ratings on stock perps240
Track record
TipRanks data via FMP| 12 months | 3 years | |
|---|---|---|
| Ratings | 111 | 372 |
| Stock | 37 | 46 |
| Buy / hold / sell | 109 / 2 / 0 | 354 / 18 / 0 |
| Upgrades / downgrades / initiations | 0 / 0 / 9 | 7 / 2 / 12 |
| Price targets hit / missed | 5 / 104 (5%) | 116 / 252 (32%) |
| Avg. return after a rating (TipRanks) | -24.9% | -5.8% |
| Best / worst call | +41.3% / -78.5% | +365.8% / -94.9% |
After buy calls: median 21-day move +0.6% · vs S&P 500 -1.2% (n = 198) · targets hit within a year 49% (n = 158)
Current calls on stock perps
| Stock | Call | Target | vs last close | Date |
|---|---|---|---|---|
| $PFE Pfizer Inc. | Buy · Maintained | $36.00 | +20.8% | Oct 26, 2026 |
| $BMY Bristol Myers Squibb | Buy · Maintained | $76.00 | +23.9% | Oct 12, 2026 |
| $REGN Regeneron Pharmaceuticals, Inc. | Buy · Maintained | $930 | +15.1% | Oct 1, 2026 |
| $LLY Eli Lilly and Company | Buy · Maintained | $1,440 | +12.6% | Sep 22, 2026 |
| $BNTX BioNTech SE | Buy · Maintained | $138 | +58.3% | Sep 15, 2026 |
| $VRTX Vertex Pharmaceuticals | Buy · Maintained | $633 | +23.6% | Aug 11, 2026 |
| $GILD Gilead Sciences, Inc. | Buy · Maintained | $180 | +13.5% | May 22, 2026 |
Recent ratings
- Oct 26, 2026 $PFE: Maintained · Buy · $36.00 · article
- Oct 12, 2026 $BMY: Maintained · Buy · $76.00 · article
- Oct 12, 2026 $BMY: Maintained · Buy · $76.00 · article
- Oct 8, 2026 $PFE: Maintained · Buy · $36.00 · article
- Oct 8, 2026 $PFE: Maintained · Buy · $36.00
- Oct 2, 2026 $PFE: Reiterated · Buy · $35.00 · article
- Oct 2, 2026 $PFE: Maintained · Buy · $35.00
- Oct 1, 2026 $REGN: Maintained · Buy · $930 · article
- Sep 22, 2026 $LLY: Maintained · Buy · $1,440 · article
- Sep 22, 2026 $LLY: Maintained · Buy · $1,440
- Sep 15, 2026 $BNTX: Maintained · Buy · $138 · article
- Sep 15, 2026 $BNTX: Maintained · Buy · $138
- Sep 1, 2026 $LLY: Maintained · Buy · $1,440 · article
- Aug 20, 2026 $BNTX: Maintained · Buy · $138 · article
- Aug 11, 2026 $VRTX: Maintained · Buy · $633 · article
- Aug 5, 2026 $PFE: Maintained · Buy · $34.00 · article
- Aug 4, 2026 $BNTX: Maintained · Buy · $138 · article
- Jul 8, 2026 $VRTX: Maintained · Buy · $610 · article
- Jul 6, 2026 $LLY: Maintained · Buy · $1,350 · article
- Jul 3, 2026 $PFE: Maintained · Buy · $34.00 · article
Akash Tewari4.8★ · 57% success · +12.3% excess return · TipRanks data via FMP · Source headlines via TheFly/StreetInsider (FMP). Reaction = venue-median perp move after our detection — an observation, not investment advice.